rxstat › Shortages › Atomoxetine

Atomoxetine (Strattera) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Nov 5, 2026

Some Atomoxetine products are in shortage in Canada (9 of 63 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2030.

A non-stimulant medication used to treat attention deficit hyperactivity disorder (ADHD).

Products affected
9 / 63
In shortage since
Jun 2, 2025
Est. full return
Dec 31, 2030
Reports on file
179
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
JAMP ATOMOXETINE
100MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02506874 · since Mar 12, 2026, est. end Dec 31, 2030 · Disruption of the manufacture of the drug.
Active shortage
JAMP ATOMOXETINE
80MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02506866 · since Mar 12, 2026, est. end Dec 31, 2030 · Disruption of the manufacture of the drug.
Active shortage
JAMP ATOMOXETINE
18MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02506815 · since Mar 12, 2026, est. end Dec 31, 2030 · Disruption of the manufacture of the drug.
Active shortage
APO-ATOMOXETINE
25MG · CAPSULE · APOTEX INC
DIN 02318040 · since Oct 13, 2026, est. end Nov 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
PMS-ATOMOXETINE
40MG · CAPSULE · PHARMASCIENCE INC
DIN 02381052 · since Sep 15, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RIVA-ATOMOXETINE
25MG · CAPSULE · LABORATOIRE RIVA INC.
DIN 02405989 · since ?, no end estimate · Delay in shipping of the drug.
Active shortage
RIVA-ATOMOXETINE
40MG · CAPSULE · LABORATOIRE RIVA INC.
DIN 02405997 · since Jun 2, 2025, no end estimate · Demand increase for the drug.
Active shortage
PMS-ATOMOXETINE
60MG · CAPSULE · PHARMASCIENCE INC
DIN 02381060 · since Sep 15, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
PMS-ATOMOXETINE
25MG · CAPSULE · PHARMASCIENCE INC
DIN 02381044 · since Sep 15, 2025, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-ATOMOXETINE
10MG · CAPSULE · TEVA CANADA LIMITED
DIN 02314541 · ended Oct 29, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-ATOMOXETINE
60MG · CAPSULE · TEVA CANADA LIMITED
DIN 02314592 · ended Jul 31, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-ATOMOXETINE
18MG · CAPSULE · TEVA CANADA LIMITED
DIN 02314568 · ended Jul 31, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Atomoxetine is currently affected by 9 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, APOTEX INC, PHARMASCIENCE INC, LABORATOIRE RIVA INC..

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug; demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Atomoxetine is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).

Recent changes

Common questions

What is Atomoxetine used for?

A non-stimulant medication used to treat attention deficit hyperactivity disorder (ADHD).

When will Atomoxetine be back in stock in Canada?

The latest manufacturer estimate is Dec 31, 2030. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Atomoxetine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (psychostimulants and nootropics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Caffeine (Peyona) No current shortage Dextroamphetamine (Dexedrine Spansule Src) No current shortage Lisdexamfetamine (Vyvanse) No current shortage Mixed Salts Amphetamine (Adderall) No current shortage Methylphenidate (Biphentin) Partial shortage 6 of 60 reported products affected · est. return Nov 15, 2026 Modafinil (Alertec) Partial shortage 1 of 6 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.